New NHMRC Investigator Grants to safeguard the brain and heart
Associate Professor Genevieve Steiner and Dr Caleb Ferguson.
Western Sydney University has been awarded two significant medical research grants worth over $2.1 million to further develop innovative strategies and approaches towards dementia prevention and treatment of atrial fibrillation, both common and devastating conditions that cut short lives across the world.
Associate Professor Genevieve Steiner, an NHMRC-ARC Dementia Research Development Fellow from the University’s NICM Health Research Institute, received $1.5 million in funding for her project, Teaching an old brain new tricks: optimising cognitive training through neuroplasticity (APP1195709).
The project aims to prevent decline in dementia as the leading cause of death of women in Australia, and the second-leading cause for all Australians, surpassing heart disease.
Associate Professor Steiner hopes this research enables older people to remain independent, stay functioning with diminished disability from dementia.
“Cognitive training is an early intervention and prevention strategy that offers hope for people with the early signs of dementia and shows promise in delaying deterioration, reducing dementia risk and its incidence,” says Associate Professor Steiner.
“The challenge, however, is to translate what we know about cognitive training to improve the everyday lives of Australians affected by the condition. This research program aims to optimise cognitive training by enhancing neuroplasticity, which is the brain’s in-built ability to adapt and rewire itself.”
The second major grant of $606,000 from the National Health and Medical Research Council (NHMRC) (APP1196262) is awarded to Dr Caleb Ferguson, Senior Research Fellow and Heart Foundation Postdoctoral Fellow from the Western Sydney Nursing and Midwifery Research Centre (Western Sydney University School of Nursing and Midwifery and Western Sydney Local Health District) and the Translational Health Research Institute (THRI).
Dr Ferguson will conduct a new trial into the world’s most common heart rhythm disorder, atrial fibrillation (AF), a condition where the heart beats irregularly. AF is a major risk factor for stroke, heart failure and dementia as well as the leading cause of cardiovascular hospitalisation in Australia.
The study, titled INFORM-AF: a randomised controlled trial to assess the efficacy of a digital education program for atrial fibrillation, will design, and evaluate a digital education intervention aimed to improve self-care practices, quality of life and reduce potentially avoidable hospitalisations.
“INFORM-AF builds on previous successful research programs at the University that partner with patients, families, clinicians and key stakeholders in educational intervention development, and evaluation,” said Dr Ferguson.
Deputy Vice-Chancellor and Vice President (Research, Enterprise and International) Professor Deborah Sweeney, commended the researchers on leading these important programs that will help improve the quality of life for many Australians.
“These grants reflect Western Sydney University’s investment and commitment to improving health in our region and internationally, and shine a spotlight on the world-class expertise and translational health capabilities in our schools and research institutes,” said Professor Sweeney.
20 May 2020
Research Media and Communications Officer
0429 951 552
Why peace negotiations haven’t gained any traction in the Ukraine war – and how the stalemate could be broken
A year after Russia’s invasion, Ukraine is in ruins. At least 8,000 civilians have died, with millions displaced. Generations of infrastructure have been destroyed. Large tracts of the environment and agricultural land have been devastated.
Opinion: Labor is odds-on for a narrow victory in NSW election, but it is far from a sure bet
A gambler would probably feel the odds favour a Labor win at the upcoming New South Wales election. But, as Scott Morrison proved in 2019, underdog status is prized in politics.
Funding success for technology to protect babies of pregnant mothers with type 1 diabetes
The University has been awarded more than $700,000, through the Medical Research Future Fund in the Clinical Trials Collaboration Round, to test whether new diabetes technology can reduce pregnancy complications among women with type 1 diabetes.